Similar Papers

Paper Title
Journal
Date
Author
ULTRA-HYPO (UHF) Compared to Moderate-HYPO (MHF) Fractionated Prostate IGRT with HDR Brachytherapy BOOST: LONG TERM Toxicity, Acceptability and Efficiency of Delivery
A.G Martin ... L Beaulieu
International Journal of Radiation Oncology*Biology*Physics | VOL. 105
A.G Martin, et. al.A.G Martin ... L Beaulieu
01 Sep 2019
Comparison of four-year toxicities and local control of ultra-hypofractionated vs moderate-hypofractionated image guided prostate radiation with HDR brachytherapy boost: A phase I-II single institution trial
Tianyu Zhou ... Nuo Xu
Clinical and translational radiation oncology | VOL. 40
Tianyu Zhou, et. al.Tianyu Zhou ... Nuo Xu
08 Feb 2023
Dosimetric Comparison Between Split Ring Applicator and Tandem and Ovoids for HDR Brachytherapy Boost in Cervical Cancer
H Hsu ... P Schiff
International Journal of Radiation Oncology*Biology*Physics | VOL. 81
H Hsu, et. al.H Hsu ... P Schiff
01 Oct 2011
6: Ultra-Hypofractionated (UHF) Compared to Moderate-Hypofractionated (MHF) Prostate IGRT with HDR Brachytherapy Boost(BB): Four-Year Toxicities and Local Control
Marie-Michèle Beaudry ... Luc Beaulieu
Radiotherapy and Oncology | VOL. 163
Marie-Michèle Beaudry, et. al.Marie-Michèle Beaudry ... Luc Beaulieu
01 Oct 2021
View more papers

More From: Radiotherapy and Oncology

Paper Title
Journal
Date
Author
Contents
-
Radiotherapy and Oncology | VOL. -
--
01 Jan 2025
Aims+Scope/Editorial Board/ Publication information
-
Radiotherapy and Oncology | VOL. -
--
01 Jan 2025
Perfect is the enemy of good: Reply to Struikmans et al
Marianne C Aznar ... Maja V Maraldo
Radiotherapy and Oncology | VOL. 202
Marianne C Aznar, et. al.Marianne C Aznar ... Maja V Maraldo
01 Jan 2025
Knowledge-based planning, multicriteria optimization, and plan scorecards: A winning combination
Carlos E Cardenas ... Richard A Popple
Radiotherapy and Oncology | VOL. 202
Carlos E Cardenas, et. al.Carlos E Cardenas ... Richard A Popple
01 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.